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1. Introduction 
Recent studies have indicated that gastrin is 
rapidly removed from the bloodstream [ 1,2] and is 
concentrated in the intestines [3,4] and to a lesser 
degree in kidney and liver [S] . It is not clear whether 
this reflects interaction with a target receptor or bind- 
ing to a degradative nzyme or transport protein. We 
have examined binding of gastrin to ligandin, a basic 
protein isolated from supernatas of human and rat 
liver, kidney and intestinal homogenates which is 
known to bind organic anions, cortisol metabolites, 
and certain carcinogens [6-81. 
2. Materials and methods 
Synthetic human gastrin was labelled with ‘*‘I 
(Radio Chemical Centre Ltd., Amersham, England) 
to a spec. act. of f 1500 mCi/mg [9], and purified 
prior to use by Sephadex chromatography. Aliquots 
(2 X lo6 cpm) “‘1 labelled-gastrin (? 0.7 ng) were 
added to 5 ml of 100 000 g supernate of a 25% 
homogenate of rat liver prepared in 0.25 M sucrose/ 
0.01 M phosphate buffer pH 7.4 and the mixture 
was chromatographed on a 100 X 2.5 cm GlOO 
Sephadex column. Elution was carried out using 
the same buffer and a pump-driven upward flow 
system at a flow rate of 15 ml/hr. The protein concen- 
tration of eluted fractions was estimated at 280 nm 
using a Unicam spectrophotometer model SP 1700. 
Radioactivity of eluted fractions was estimated on a 
Packard Autogamma spectrometer. The column was 
characterised by addition of blue dextran and 
’ 251-labelled albumin [lo]. Labelled gastrin was also 
passed through the column in the absence of liver 
300 
supernate. The ligandin peak was identified by its 
binding with sodium sulfobromophthalein (BSP) 
and also by immuno-diffusion against rabbit anti-rat 
liver ligandin prepared as described by Fleischner 
et al. [7]. The displacement of radioactive gastrin 
from ligandin was measured by addition of a gross 
excess (100 pg) of non-radioactive synthetic human 
gastrin to the supernate prior to chromatography. 
Binding of ‘2sI-labelled glucagon and insulin to 
ligandin was also examined. In other experiments 
unlabelled synthetic human gastrin was added to liver 
supernate and the gastrin content of the chromato- 
graphed samples estimated by radioimmunoassay [ 111, 
using an antiserum with a high affinity (3.6 X 10” 
L/mol) [ 121 for synthetic human gastrin. 
3. Results and discussion 
The elution profde of ’ *‘I-labelled albumin and 
BSP are shown in fig.1 and correspond to those 
previously described [6,13]. Labelled gastrin eluted 
at approx. 3 times the void vol of the column. Only 
the major BSP binding peak contained ligandin as 
measured by immunodiffusion analysis. Fig.2 shows 
the elution profile obtained when ’ *‘I-gastrin was 
added to the supernate of 25% liver homogenate. 
Approximately 80% of the radioactively labelled 
gastrin was eluted in the peak containing ligandin. 
Furthermore, this peak is clearly distinguished from 
that of gastrin itself and gastrin bound to other 
proteins, for example albumin. Addition of an 
excess of cold gastrin to the liver supernatant, 
decreased recovery of radioactive gastrin in the 
ligandin peak to less than 40%. It is thus apparent 
that labelled gastrin bound to ligandin could be 
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Fig.1. Sephadex (GlOO) elution profile of 100 000 g supemate of 25% homogenate of rat liver containing “51-labelled albumin 
(m-9) and BSP (A-A) (See text for details of chromatography). 
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Fig.2. Sephadex (GlOO) elution profile of 100 000 g supernate of 25% homogenate of rat liver with added ” Tlabelled gas&in 
(=--¤). 
301 
Volume 52, number 2 FEBS LETTERS April 1975 
Fig.3. Sephadex (GlOO) elution profile of 100 000 g supernate of 25% homogenate of rat liver with added unlabelled gastrin 
(e--4). Gastrin in eluates was measured by radioimmunoassay. 
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displaced by addition of cold gastrin to the liver 
supernate prior to chromatography. The fact that 
4% of the label was still recoverable in the ligandin 
peak may reflect alteration of the labelled gastrin 
molecule either during the process of labelling, or 
its coupling to ligandin, so that cold gastrin competes 
unfavourably with binding sites to cause displacement. 
Radioimmunoassay of the eluted material following 
addition of unlabelled gastrin to liver supernate also 
appears to demonstrate binding of gastrin to ligandin 
as shown in fig.3. The finding that gastrin bound to 
ligandin was measurable by immunoassay may reflect 
either a higher affinity for gastrin of the antiserum 
compared with ligandin, or may represent recognition 
of different sites of the gastrin molecule by these two 
proteins. Nevertheless, further studies with purified 
ligandin would be required to determine the kinetics of 
this interaction. The failure of liver supernate to 
significantly bind ’ 251 itself excludes the possibility 
that we were dealing with iodine and not gastrin bind- 
ing to ligandin, and this specificity is further shown 
by the absence of glucagon or insulin binding to the 
transport protein. The binding of gastrin to ligandin 
may well be related to the highly acidic nature of the 
gastrin molecules with its large number of charged 
glutamic acid residues. Other studies using synthetic 
peptides lacking these residues should resolve this 
question. 
Ligandin, the major organic anion binding protein 
in liver, kidney and proximal small bowel, has been 
shown to be important in uptake of drugs, dyes, 
cholecystographic agents, hormones and carcinogens 
when given in vivo or when added in vitro to super- 
natant fractions prepared from homogenates of these 
tissues [6-81. Phylogenetic [ 141 and ontogenetic [ 151 
studies reveal correlation between appearance of 
ligandin in liver and the ability to transfer organic 
anions from plasma into the liver. Binding of gastrin 
to ligandin may explain the uptake of this hormone 
at high delivery rates by the liver [ 161. The findings 
that gastrin binds in vitro to ligandin may indicate a 
functional role of the latter protein in the uptake of 
this hormone by the liver [ 161 and correlates with the 
observation that gastrin is concentrated in the kidney 
and gut [3-51. 
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